Evidence map›Paper›PMID 32390069›Full record

ArticleThe AAPS journal2020

Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications.

Terri D LaCount, Qian Zhang, Jinsong Hao, Priyanka Ghosh, Sam G Raney, Arjang Talattof, Gerald B Kasting, S Kevin Li

Abstract read
In one paragraph

Article in The AAPS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Transdermal permeation of curcumin promoted by choline geranate ionic liquid: Potential for the treatment of skin diseases.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Terri D LaCountDivision of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati Academic Health Center, 231 Albert Sabin Way, Cincinnati, Ohio, 45267-0514, USA.
Qian ZhangDivision of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati Academic Health Center, 231 Albert Sabin Way, Cincinnati, Ohio, 45267-0514, USA.
Jinsong HaoDepartment of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, Huntington, West Virginia, 25755, USA.
Priyanka GhoshOffice of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
Sam G RaneyOffice of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
Arjang TalattofOffice of Research and Standards, Office of Generic Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
Gerald B KastingDivision of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati Academic Health Center, 231 Albert Sabin Way, Cincinnati, Ohio, 45267-0514, USA. Gerald.Kasting@uc.edu.
S Kevin LiDivision of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati Academic Health Center, 231 Albert Sabin Way, Cincinnati, Ohio, 45267-0514, USA.

Funding

Tiered Testing Strategy for Assessing Thermal Effects on Transdermal ProductsU01FD004942 · FDA · UNIVERSITY OF CINCINNATI · PI LI, KEVIN S. · 2013 to 2015
$994k
FDA HHS U01 FD004942
6 · The paper itself

Abstract

A computational model was developed to better understand the impact of elevated skin temperatures on transdermal drug delivery and dermal clearance. A simultaneous heat and mass transport model with emphasis on transdermal delivery system (TDS) applications was developed to address transient and steady-state temperature effects on dermal absorption. The model was tested using representative data from nicotine TDS applied to human skin either in vitro or in vivo. The approximately 2-fold increase of nicotine absorption with a 10°C increase in skin surface temperature was consistent with a 50-65 kJ/mol activation energy for diffusion in the stratum corneum, with this layer serving as the primary barrier for nicotine absorption. Incorporation of a dermal clearance component into the model revealed efficient removal of nicotine via the dermal capillaries at both normal and elevated temperatures. Two-compartment pharmacokinetic simulations yielded systemic drug concentrations consistent with the human pharmacokinetic data. Both in vitro skin permeation and in vivo pharmacokinetics of nicotine delivered from a marketed TDS under normal and elevated temperatures can be satisfactorily described by a simultaneous heat and mass transfer computational model incorporating realistic skin barrier properties and dermal clearance components.

Indexed as

Patient-Specific ModelingAdministration, CutaneousAdministration, TopicalCapillariesHumansMetabolic Clearance RateNicotineSkin AbsorptionSkin TemperatureTransdermal PatchNicotineheat and mass transportheat-enhancedhuman skinmathematical modelnicotine transdermal

Identifiers

PMID32390069
PMCPMC7644225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.